Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Bue

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Ugeskrift for Laeger|November 6, 1989
[Injury patterns in Danish competitive swimming]K Bak, P Bue, G Olsson
International Journal of Oncology|August 12, 2000
Binding of 125I after administration of 125I-EGF-dextran, 125I-EGF or 125I to human bladder cancer spheroidsA Sjöström, P Bue, P Malmstrom, et al.
International Journal of Cancer|February 7, 1997
Binding, internalization and degradation of EGF-dextran conjugates in two human bladder-cancer cell linesA Sjöström, P Bue, P U Malmström, et al.
Cancer|December 24, 1997
The potential of radiolabeled EGF-dextran conjugates in the treatment of urinary bladder carcinomaP Bue, M Márquez, P U Malmström, et al.
European Urology|November 30, 2000
Intravesical administration of EGF- dextran conjugates in patients with superficial bladder cancerP Bue, A R Holmberg, M Márquez, et al.
International Journal of Cancer|April 16, 1998
Expression of epidermal growth factor receptor in urinary bladder cancer metastasesP Bue, K Wester, A Sjöström, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Ugeskrift for Laeger|November 6, 1989
[Injury patterns in Danish competitive swimming]K Bak, P Bue, G Olsson
International Journal of Oncology|August 12, 2000
Binding of 125I after administration of 125I-EGF-dextran, 125I-EGF or 125I to human bladder cancer spheroidsA Sjöström, P Bue, P Malmstrom, et al.
International Journal of Cancer|February 7, 1997
Binding, internalization and degradation of EGF-dextran conjugates in two human bladder-cancer cell linesA Sjöström, P Bue, P U Malmström, et al.
Cancer|December 24, 1997
The potential of radiolabeled EGF-dextran conjugates in the treatment of urinary bladder carcinomaP Bue, M Márquez, P U Malmström, et al.
European Urology|November 30, 2000
Intravesical administration of EGF- dextran conjugates in patients with superficial bladder cancerP Bue, A R Holmberg, M Márquez, et al.
International Journal of Cancer|April 16, 1998
Expression of epidermal growth factor receptor in urinary bladder cancer metastasesP Bue, K Wester, A Sjöström, et al.
Pageof 1